Voting Rights Announcements | 8 October 2014 14:27


STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG 

08.10.2014 14:27

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


1. Threadneedle Asset Management UK Limited

Threadneedle Asset Management UK Limited, London, UK, has notified us
pursuant to sec. 21 para. 1 WpHG on 6 October 2014, that on 18 April 2013
the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany,
ISIN: DE0007289001 went above the threshold of 5% and that the percentage
of voting rights on that day amounted to 5.35% (628,462 voting rights).
Threadneedle Asset Management UK Limited has notified us that these voting
rights of 5.35% (628,462 voting rights) are attributable to Threadneedle
Asset Management UK Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 in
connection with sent. 2 WpHG.

The voting rights were attributed to Threadneedle Asset Management UK
Limited inter alia from Threadneedle Investment Funds ICVC, being a
shareholder holding 3% or more of the voting rights in STRATEC Biomedical
AG.


2. TAM UK Holdings Limited

TAM UK Holdings Limited, London, UK, has notified us pursuant to sec. 21
para. 1 WpHG on 6 October 2014, that on 18 April 2013 the share of voting
rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001
went above the threshold of 5% and that the percentage of voting rights on
that day amounted to 5.35% (628,462 voting rights). TAM UK Holdings Limited
has notified us that these voting rights of 5.35% (628,462 voting rights)
are attributable to TAM UK Holdings Limited pursuant to sec. 22 para. 1
sent. 1 no. 6 in connection with sent. 2 WpHG.

The voting rights were attributed to TAM UK Holdings Limited inter alia
from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or
more of the voting rights in STRATEC Biomedical AG.


3. Threadneedle Holdings Limited

Threadneedle Holdings Limited, London, UK, has notified us pursuant to sec.
21 para. 1 WpHG on 6 October 2014, that on 18 April 2013 the share of
voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE0007289001 went above the threshold of 5% and that the percentage of
voting rights on that day amounted to 5.35% (628,462 voting rights).
Threadneedle Holdings Limited has notified us that these voting rights of
5.35% (628,462 voting rights) are attributable to Threadneedle Holdings
Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent.
2 WpHG.

The voting rights were attributed to Threadneedle Holdings Limited inter
alia from Threadneedle Investment Funds ICVC, being a shareholder holding
3% or more of the voting rights in STRATEC Biomedical AG.



08.10.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------